Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

[O. Spigset and colleagues reply].

Spigset O, Samdal H, Harg P, Werner MC, Fjermeros K.

Tidsskr Nor Laegeforen. 2015 Aug 11;135(14):1221. doi: 10.4045/tidsskr.15.0708. eCollection 2015 Aug 11. Norwegian. No abstract available.

2.

[Patient reporting of adverse drug reactions in Norway 2010-13].

Fjermeros K, Werner MC, Harg P, Samdal H, Slørdal L, Spigset O.

Tidsskr Nor Laegeforen. 2015 Mar 24;135(6):536-40. doi: 10.4045/tidsskr.14.1388. eCollection 2015 Mar 24. Norwegian.

3.

Detection of the gravitational lens magnifying a type Ia supernova.

Quimby RM, Oguri M, More A, More S, Moriya TJ, Werner MC, Tanaka M, Folatelli G, Bersten MC, Maeda K, Nomoto K.

Science. 2014 Apr 25;344(6182):396-9. doi: 10.1126/science.1250903.

4.

Astronomy: More medieval clues to cosmic-ray event.

Gibbons GW, Werner MC.

Nature. 2012 Jul 25;487(7408):432. doi: 10.1038/487432c. No abstract available.

PMID:
22836986
5.

Child sexual abuse in clinical and forensic psychiatry: a review of recent literature.

Werner J, Werner MC.

Curr Opin Psychiatry. 2008 Sep;21(5):499-504. doi: 10.1097/YCO.0b013e328305e4b0. Review.

PMID:
18650695
6.

Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.

Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF 3rd, Werb Z, Kalluri R.

PLoS Med. 2006 Apr;3(4):e100. Epub 2006 Mar 7.

7.

Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.

Kalluri R, Torre A, Shield CF 3rd, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UM, van den Heuvel LP, Grossman R, Aradhye S, Neilson EG.

Transplantation. 2000 Feb 27;69(4):679-83.

PMID:
10708133
8.

Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.

Werner MC, Costa Rosa LF, Romaldini JH, Curi R.

Cell Biochem Funct. 1996 Jun;14(2):97-104.

PMID:
8640958
9.

The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine.

Bromberg N, Romaldini JH, Werner RS, Sgarbi JA, Werner MC.

J Endocrinol Invest. 1992 Mar;15(3):191-5.

PMID:
1624679
10.

Adverse effects related to antithyroid drugs and their dose regimen.

Romaldini JH, Werner MC, Bromberg N, Werner RS.

Exp Clin Endocrinol. 1991 May;97(2-3):261-4. No abstract available.

PMID:
1915643
11.

The evolution of the ophthalmopathy during antithyroid drug therapy and its relationship with serum thyroglobulin and antithyroglobulin antibody in patients with Basedow's disease.

Bromberg N, Werner RS, Sgarbi JA, Werner MC, Romaldini JH.

Exp Clin Endocrinol. 1991 May;97(2-3):354-7. No abstract available.

PMID:
1717300
13.

Adverse effects related to thionamide drugs and their dose regimen.

Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS.

Am J Med Sci. 1989 Apr;297(4):216-9.

PMID:
2523194
14.

Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.

Romaldini JH, Werner MC, Rodrigues HF, Teixeira VL, Werner RS, Farah CS, Bromberg N.

J Endocrinol Invest. 1986 Jun;9(3):233-8.

PMID:
2428860
15.

Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.

Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS, Reis LC.

J Clin Endocrinol Metab. 1983 Sep;57(3):563-70.

PMID:
6192139

Supplemental Content

Loading ...
Support Center